ORKA
Oruka Therapeutics
ORKA
ORKA
22 hedge funds and large institutions have $2.6M invested in Oruka Therapeutics in 2022 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.01% more ownership
Funds ownership: 0.65% → 0.66% (+0.01%)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Holders
22
Holding in Top 10
–
Calls
$223K
Puts
$141K
Top Buyers
| 1 | +$123K | |
| 2 | +$55K | |
| 3 | +$50K | |
| 4 |
MAM
Marquette Asset Management
Minneapolis,
Minnesota
|
+$40K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$31.8K |
Top Sellers
| 1 | -$123K | |
| 2 | -$69K | |
| 3 | -$38.8K | |
| 4 |
Simplex Trading
Chicago,
Illinois
|
-$24.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$6.1K |